Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121176212 | 12117621 | 2 | F | 20160205 | 20160915 | 20160226 | 20160921 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-011164 | BRISTOL MYERS SQUIBB | 79.01 | YR | F | Y | 0.00000 | 20160921 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
121176212 | 12117621 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | 5E82990B | 21986 | 100 | MG | QD | ||||||
121176212 | 12117621 | 2 | SS | SPRYCEL | DASATINIB | 1 | Oral | 50 UNK, UNK | 21986 | 50 | MG | QD | |||||||
121176212 | 12117621 | 3 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 5 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 6 | C | MIDODRINE | MIDODRINE | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 7 | C | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 8 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Unknown | U | 0 | ||||||||||
121176212 | 12117621 | 9 | C | PROMETHAZINE | PROMETHAZINEPROMETHAZINE HYDROCHLORIDE | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
121176212 | 12117621 | 1 | Chronic myeloid leukaemia |
121176212 | 12117621 | 3 | Product used for unknown indication |
121176212 | 12117621 | 4 | Product used for unknown indication |
121176212 | 12117621 | 5 | Product used for unknown indication |
121176212 | 12117621 | 6 | Product used for unknown indication |
121176212 | 12117621 | 7 | Product used for unknown indication |
121176212 | 12117621 | 8 | Product used for unknown indication |
121176212 | 12117621 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
121176212 | 12117621 | HO |
121176212 | 12117621 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
121176212 | 12117621 | Bronchitis | |
121176212 | 12117621 | Dehydration | |
121176212 | 12117621 | Pulmonary oedema | |
121176212 | 12117621 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
121176212 | 12117621 | 1 | 20151211 | 0 |